Tianlun Kang

Tianlun Kang

Auto-generated profile, based on publicly available information

Tianlun Kang

Department of Rheumatology Dongfang Hospital Beijing University of Chinese Medicine Beijing China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2024 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
CZChen Zhang
Chen Zhang
SLSiyi Lu
Siyi Lu
TKTianlun Kang
Tianlun Kang
FMFanzhang Meng
Fanzhang Meng
TQTangliang Qian
Tangliang Qian
XHXiujuan Hou
Xiujuan Hou

1 October 2023 in Clinical, Cosmetic and Investigational Dermatology
Verified
Journal Article
Open access
PDF file
CZChen Zhang
Chen Zhang
TKTianlun Kang
Tianlun Kang
TQTangliang Qian
Tangliang Qian
MMMingwei Ma
Mingwei Ma
XHXiujuan Hou
Xiujuan Hou
CLChen Li
Chen Li
Secukinumab, a monoclonal antibody targeting interleukin-17 (IL-17), has exhibited encouraging results in the therapeutic management of palmoplantar pustulosis (PPP). The development of alopecia areata (AA) is closely related to IL-17, and IL-17A inhibitors were considered as a potential treatment modality. Therefore, the development of AA during secukinumab treatment for PPP is a rare adverse event that has been rarely reported worldwide. Here we report a 35-year-old female patient with PPP who developed AA after completing the induction period of secukinumab treatment. Discontinuing secukinumab and initiating treatment with tofacitinib resulted in a significant improvement in both PPP and AA. The emergence of AA in this patient can be attributed to paradoxical skin reactions associated with IL-17 inhibitors. Tofacitinib appears to alleviate biologic-induced AA during PPP syndrome treatment.

9 October 2023 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
MDMengmeng Du
Mengmeng Du
XHXiujuan Hou
Xiujuan Hou
SLSiyi Lu
Siyi Lu
TKTianlun Kang
Tianlun Kang
YLYuan Li
Yuan Li
RWRuoyi Wang
Ruoyi Wang

6 April 2023 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
FCFengjiao Cao
Fengjiao Cao
XHXiujuan Hou
Xiujuan Hou
TKTianlun Kang
Tianlun Kang
XSXiaojun Shi
Xiaojun Shi
WMWeiguo Ma
Weiguo Ma
CLChen Li
Chen Li

10 July 2024 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
FMFanzhang Meng
Fanzhang Meng
SLSiyi Lu
Siyi Lu
YLYingzi Li
Yingzi Li
CZChen Zhang
Chen Zhang
TKTianlun Kang
Tianlun Kang
XHXiujuan Hou
Xiujuan Hou

24 January 2024 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
TKTianlun Kang
Tianlun Kang
YXYajing Xi
Yajing Xi
SLSiyi Lu
Siyi Lu
TQTangliang Qian
Tangliang Qian
MDMengmeng Du
Mengmeng Du
XHXiujuan Hou
Xiujuan Hou